Project CASCADE: Community and Academic Synergy for Cancer Survivorship Care Delivery Enhancement

NCT ID: NCT06883838

Last Updated: 2025-10-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

5584 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-01

Study Completion Date

2029-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to implement a clinic-level cancer survivorship care delivery intervention in partnership with community health center clinicians, patients, and community representatives to test effectiveness of the intervention to improve patient and clinician outcomes and to evaluate implementation of the intervention using an iterative, concurrent mixed-methods approach guided by the Practice Change Model.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Survivorship

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Stepped-wedge cluster randomized trial (SW-CRT). There will be 4 clusters (CHCs) having 2 practices each.
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Step 1 (2 clinics)-6 months control then 12 months intervention

Group Type EXPERIMENTAL

Survivorship care delivery intervention

Intervention Type BEHAVIORAL

Guided by the Practical, Robust Implementation and Sustainability Model (PRISM), the intervention includes three evidence-based components:

1. Training: This will include provider-to-provider tele-mentoring using Enhancing Community Health Outcomes (ECHO).
2. Tracking: This includes systematically assessing cancer history and monitoring survivors' care to plan and organize subsequent care.
3. Coordinating care for cancer survivors. Each clinic leader will designate a staff member (or members) as the care coordinator champion after exploring current clinic staff, skills, and capacity of various staff roles.

Step 2 (2 clinics)-12 months control then 12 months intervention

Group Type EXPERIMENTAL

Survivorship care delivery intervention

Intervention Type BEHAVIORAL

Guided by the Practical, Robust Implementation and Sustainability Model (PRISM), the intervention includes three evidence-based components:

1. Training: This will include provider-to-provider tele-mentoring using Enhancing Community Health Outcomes (ECHO).
2. Tracking: This includes systematically assessing cancer history and monitoring survivors' care to plan and organize subsequent care.
3. Coordinating care for cancer survivors. Each clinic leader will designate a staff member (or members) as the care coordinator champion after exploring current clinic staff, skills, and capacity of various staff roles.

Step 3 (2 clinics)-18 months control then 12 months intervention

Group Type EXPERIMENTAL

Survivorship care delivery intervention

Intervention Type BEHAVIORAL

Guided by the Practical, Robust Implementation and Sustainability Model (PRISM), the intervention includes three evidence-based components:

1. Training: This will include provider-to-provider tele-mentoring using Enhancing Community Health Outcomes (ECHO).
2. Tracking: This includes systematically assessing cancer history and monitoring survivors' care to plan and organize subsequent care.
3. Coordinating care for cancer survivors. Each clinic leader will designate a staff member (or members) as the care coordinator champion after exploring current clinic staff, skills, and capacity of various staff roles.

Step 4 (2 clinics)- 24 months control then 12 months intervention

Group Type EXPERIMENTAL

Survivorship care delivery intervention

Intervention Type BEHAVIORAL

Guided by the Practical, Robust Implementation and Sustainability Model (PRISM), the intervention includes three evidence-based components:

1. Training: This will include provider-to-provider tele-mentoring using Enhancing Community Health Outcomes (ECHO).
2. Tracking: This includes systematically assessing cancer history and monitoring survivors' care to plan and organize subsequent care.
3. Coordinating care for cancer survivors. Each clinic leader will designate a staff member (or members) as the care coordinator champion after exploring current clinic staff, skills, and capacity of various staff roles.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Survivorship care delivery intervention

Guided by the Practical, Robust Implementation and Sustainability Model (PRISM), the intervention includes three evidence-based components:

1. Training: This will include provider-to-provider tele-mentoring using Enhancing Community Health Outcomes (ECHO).
2. Tracking: This includes systematically assessing cancer history and monitoring survivors' care to plan and organize subsequent care.
3. Coordinating care for cancer survivors. Each clinic leader will designate a staff member (or members) as the care coordinator champion after exploring current clinic staff, skills, and capacity of various staff roles.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

-at least one visit to the Community Health Centers (CHCs) in the prior year


-employed clinicians (e.g. physicians, nurses, pharmacists, or other allied health professionals) and non-clinician staff of the participating CHC clinics

Exclusion Criteria

\- no history of cancer recorded in the problem list or past medical history in the medical record
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

The University of Texas Health Science Center, Houston

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bijal.A.Balasubramanian

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bijal Balasubramanian, MBBS, PhD

Role: PRINCIPAL_INVESTIGATOR

The University of Texas Health Science Center, Houston

Simon Craddock Lee, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Kansas Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University of Texas Health Science Center, Houston

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U01CA290663

Identifier Type: NIH

Identifier Source: secondary_id

View Link

HSC-SPH-24-0777

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.